Lipid composition influences the release of Alzheimer's amyloid β-peptide from membranes

被引:75
|
作者
Lemkul, Justin A. [1 ]
Bevan, David R. [1 ]
机构
[1] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA
基金
美国国家科学基金会;
关键词
simulation; amyloid; molecular dynamics; membrane; MOLECULAR-DYNAMICS SIMULATIONS; PARTICLE MESH EWALD; SOLID-STATE NMR; SECONDARY STRUCTURE; CONSTANT-TEMPERATURE; ENDOGENOUS SEED; GAMMA-SECRETASE; PROTEIN; DISEASE; GANGLIOSIDES;
D O I
10.1002/pro.678
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The behavior of the amyloid beta-peptide (A beta) within a membrane environment is integral to its toxicity and the progression of Alzheimer's disease. Ganglioside GM1 has been shown to enhance the aggregation of A beta, but the underlying mechanism is unknown. Using atomistic molecular dynamics simulations, we explored the interactions between the 40-residue alloform of A beta (A beta(40)) and several model membranes, including pure palmitoyloleoylphosphatidylcholine (POPC) and palmitoyloleoylphosphatidylserine (POPS), an equimolar mixture of POPC and palmitoyloleoylphosphatidylethanolamine (POPE), and lipid rafts, both with and without GM1, to understand the behavior of A beta(40) in various membrane microenvironments. A beta(40) remained inserted in POPC, POPS, POPC/POPE, and raft membranes, but in several instances exited the raft containing GM1. A beta(40) interacted with GM1 largely through hydrogen bonding, producing configurations containing beta-strands with C-termini that, in some cases, exited the membrane and became exposed to solvent. These observations provide insight into the release of A beta from the membrane, a previously uncharacterized process of the A beta aggregation pathway.
引用
收藏
页码:1530 / 1545
页数:16
相关论文
共 50 条
  • [41] Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
    Haass, Christian
    Selkoe, Dennis J.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (02) : 101 - 112
  • [42] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Higuchi, M
    Saido, TC
    PHARMACOLOGY & THERAPEUTICS, 2005, 108 (02) : 129 - 148
  • [43] The redox chemistry of the Alzheimer's disease amyloid β peptide
    Smith, Danielle G.
    Cappai, Roberto
    Barnham, Kevin J.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (08): : 1976 - 1990
  • [44] Metabolic regulation of amyloid β peptide and Alzheimer's disease
    Saido, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S204 - S204
  • [45] β-amyloid peptide as a target for treatment of Alzheimer's disease
    Conde, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (04) : 503 - 512
  • [46] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Saido, TC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 51P - 51P
  • [47] The amyloid peptide and its precursor in Alzheimer's disease
    Octave, JN
    REVIEWS IN THE NEUROSCIENCES, 1995, 6 (04) : 287 - 316
  • [48] The Amyloid Hypothesis and the clearance and degradation of Alzheimer's β-peptide
    LeVine, H
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (03) : 303 - 314
  • [49] The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
    Muirhead, Kirsty E. A.
    Borger, Eva
    Aitken, Laura
    Conway, Stuart J.
    Gunn-Moore, Frank J.
    BIOCHEMICAL JOURNAL, 2010, 426 : 255 - 270
  • [50] β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease
    Sun, Xiaojuan
    Chen, Wei-Dong
    Wang, Yan-Dong
    FRONTIERS IN PHARMACOLOGY, 2015, 6